398 related articles for article (PubMed ID: 25274901)
1. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
[TBL] [Abstract][Full Text] [Related]
2. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
Kim HA; An JM; Nam JY; Jeon JY; Suh CH
J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
[TBL] [Abstract][Full Text] [Related]
3. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
[TBL] [Abstract][Full Text] [Related]
4. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
[TBL] [Abstract][Full Text] [Related]
5. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.
Jung SY; Park YB; Ha YJ; Lee KH; Lee SK
J Rheumatol; 2010 May; 37(5):1029-34. PubMed ID: 20231196
[TBL] [Abstract][Full Text] [Related]
6. Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease.
Han JH; Suh CH; Jung JY; Ahn MH; Kwon JE; Yim H; Kim HA
J Rheumatol; 2017 Jun; 44(6):740-747. PubMed ID: 28365573
[TBL] [Abstract][Full Text] [Related]
7. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels.
Myles A; Viswanath V; Singh YP; Aggarwal A
J Rheumatol; 2011 Sep; 38(9):1994-9. PubMed ID: 21724696
[TBL] [Abstract][Full Text] [Related]
8. Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash.
Jung JY; Suh CH; Sohn S; Nam JY; Kim HA
Clin Rheumatol; 2016 Aug; 35(8):1937-1942. PubMed ID: 27225247
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
[TBL] [Abstract][Full Text] [Related]
10. Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.
Guo Q; Zha X; Li C; Jia Y; Zhu L; Guo J; Su Y
Clin Rheumatol; 2016 Jan; 35(1):73-9. PubMed ID: 26547221
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.
Priori R; Colafrancesco S; Alessandri C; Minniti A; Perricone C; Iaiani G; Palazzo D; Valesini G
J Rheumatol; 2014 Jun; 41(6):1118-23. PubMed ID: 24786926
[TBL] [Abstract][Full Text] [Related]
12. Increased ferritin response in adult Still's disease: specificity and relationship to outcome.
Evensen KJ; Swaak TJ; Nossent JC
Scand J Rheumatol; 2007; 36(2):107-10. PubMed ID: 17476616
[TBL] [Abstract][Full Text] [Related]
13. The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease.
Zou YQ; Lu LJ; Li SJ; Zeng T; Wang XD; Bao CD; Chen SL; Yang CD
Clin Biochem; 2008 May; 41(7-8):519-24. PubMed ID: 18261992
[TBL] [Abstract][Full Text] [Related]
14. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
[TBL] [Abstract][Full Text] [Related]
15. Serum cytokine profiles in patients with adult onset Still's disease.
Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis.
Rau M; Schiller M; Krienke S; Heyder P; Lorenz H; Blank N
J Rheumatol; 2010 Nov; 37(11):2369-76. PubMed ID: 20810496
[TBL] [Abstract][Full Text] [Related]
17. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
[TBL] [Abstract][Full Text] [Related]
18. Adult-onset Still's disease: still a diagnosis of exclusion. A nested case-control study in patients with fever of unknown origin.
Vanderschueren S; Hermans F; De Munter P; Knockaert D
Clin Exp Rheumatol; 2012; 30(4):514-9. PubMed ID: 22510428
[TBL] [Abstract][Full Text] [Related]
19. The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease.
Han JH; Ahn MH; Jung JY; Suh CH; Kwon JE; Yim H; Kim HA
Clin Exp Rheumatol; 2019; 37 Suppl 121(6):67-73. PubMed ID: 31287410
[TBL] [Abstract][Full Text] [Related]
20. [Ferritin levels in adult Still's disease].
Flatau E; Reichman N; Kaufman N
Harefuah; 1999 Sep; 137(5-6):200-1, 263, 262. PubMed ID: 10959321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]